RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Date:

November 15, 2024

Robert F. Kennedy Jr. would create “significantly more volatility” in health markets if he is confirmed as Secretary of Health and Human Services, making navigating policy risks far more challenging, according to Raymond James analyst Chris Meekins.

Source link

A Croatian corruption investigation snares the health minister and several others

Saie Beauty: 6 Design Ideas We’re Stealing From the Scandi Minimalist-Inspired Headquarters

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Recent posts

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Oil turns higher for the week after hurricane Francine landfall

Fed’s Barkin: More data is needed before any changes are made to interest rates

Bond investors position for new debt from Goldman Sachs and Morgan Stanley

Expect the stock market’s winners to keep on winning — until this happens, Morgan Stanley’s top strategist says

Nike stock falls, as executives say Q4 results ‘highlighted challenges’ with demand

Delta hires law firm seeking damages from CrowdStrike, Microsoft after massive tech outage: report

Oil prices attempt to stabilize after ending at 7-week lows

Strong fertility, contact-lens sales help fuel stock rally for Cooper Companies

Polymarket says the whale betting heavily on Trump is a French individual

Here’s how stocks have performed under Biden and Harris vs. under Trump

Here’s how economic issues could help Republicans take back the U.S. Senate

This week’s U.S. inflation report could have serious implications for stocks

Tommy Bahama maker says shoppers are still ‘more cautious than originally anticipated,’ but cites this improvement

Dogecoin soars as altcoins look to benefit from Trump presidency

Related articles

Manufacturing activity surges in New York region to highest level in nearly three years

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Cava is riding a strong wave, but the stock’s quadrupling in 2024 has analysts wary

Company

Follow us